Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学TROP2 ADC, Breast Cancer

Jennifer Moliterno

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Medical Oncologist, Breast and GYN Oncology

24
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Jennifer Moliterno is a medical oncologist at MSK specializing in breast and gynecological cancers. She is an investigator in trials of datopotamab deruxtecan including TROPION-PanTumor01 and TROPION-Breast01, and studies TROP2 expression as a pan-tumor biomarker. Her research examines optimal sequencing of TROP2-directed ADCs and mechanisms of cross-ADC resistance.

Share:

🧪Research Fields 研究领域

datopotamab deruxtecan Dato-DXd
TROP2 lung cancer ADC
TROPION-PanTumor01
ADC cross-tumor activity
TROP2 expression heterogeneity

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jennifer Moliterno 的研究动态

Follow Jennifer Moliterno's research updates

留下邮箱,当我们发布与 Jennifer Moliterno(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment